5.960 -0.080 (-1.32%) 01-15 17:35 |
|
Open: | 5.940 |
High: | 5.960 |
Low: | 5.840 |
Pre. close: | 6.040 |
Volume: | 2,597 |
Avg. volume: | 17,424 |
MA (50): | 5.477 |
MA (200): | 8.207 |
Year high: | 13.300 |
Year low: | 2.890 |
Market cap: | 167(M) |
EPS: | -0.55 |
PE ratio: | -10.84 |
SELL | BUY |
HeikinAshi: | |
Kaufmans AMA: | |
Chandelier (20): | |
MA (5): | |
MA (50): | |
MACD (26,12,9): | |
Slow KDJ (14,3): | |
RSI (14): | |
CCI (20): |
Thu, 09 Jan 2025
Hyloris Pharmaceuticals Announces Warrant Plan Expiry and Share Capital Details - TipRanks
Mon, 30 Dec 2024
Hyloris Pharmaceuticals’ Positive Study Boosts European Expansion - TipRanks
Fri, 13 Sep 2024
Hyloris Pharmaceuticals SA (EBR:HYL) CEO Stijn Van Rompay's holdings dropped 14% in value as a result of the recent pullback - Simply Wall St
Fri, 08 Mar 2024
Hyloris to Report 2023 Full-Year Results on 14 March 2024 - Yahoo Finance
Tue, 27 Feb 2024
Hyloris Announces Launch of Maxigesic® IV in the U.S. and approval In Canada - GlobeNewswire
Wed, 17 Jan 2024
Pleco Therapeutics Receive FDA Orphan Drug Designation - European Pharmaceutical Manufacturer
©NovaStocks.com | euro Stocks quote, company news, stock charts, technical analysis. Data and information is provided for informational purposes only, is not intended for trading purposes and is not investment advice. Neither NovaStocks.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. Market data provided by: Financial Modeling Prep
Privacy Policy: Third parties, including Google, may be placing and reading cookies on your browsers, or other methods to collect information as a result of ad serving on this website. Third parties' use of advertising cookies enables it and its partners to serve ads to you based on your visit to this site and/or other sites on the Internet. You may opt out of personalized advertising by visiting Ads Settings. If you choose to use this website, you agree to the collection and use of information in relation to this policy. The information collected is used for providing and improving the ads Service. We will not use or share information with anyone, and we do not store any data from users.